Open AccessDesign and Challenges of the Randomized Evaluation of Normal versus Augmented Level Replacement Therapy (RENAL) Trial: High-Dose versus Standard-Dose Hemofiltration in Acute Renal Failure
Author(s) -
Sunny Eloot,
Wim Van Biesen,
Annemieke Dhondt,
E Billiet,
Pascal Verdonck,
Raymond Vanholder,
Martin Válek,
František Lopot,
Sylvie Dusilová-Sulková,
Vladimír Polakovič,
R. T. Noel Gibney,
Sean M. Bagshaw,
Demetrios J. Kutsogiannis,
C. Johnston,
Maria Alquist,
Juan P. Bosch,
Na Jiang,
Jiaqi Qian,
Aiwu Lin,
Bengt Lindholm,
Jonas Axelsson,
Qiang Yao,
Jongha Park,
Hyun Chul Chung,
Jong Soo Lee,
Byeong Man Lee,
Dong-Min Kim,
Jae Cheol Hwang,
MinWoo Jo,
Maengseok Noh,
Jüng Woo Shin,
Jihong Yang,
Lei Cheng,
Yan Gu,
Lijun Tang,
Tao Wang,
Marianne Lindholm,
H. F. Woods,
Chen Ting Cheng,
Po Sung Lim
Publication year - 2008
Publication title -
blood purification
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.686
H-Index - 57
eISSN - 1421-9735
pISSN - 0253-5068
DOI - 10.1159/000148400
Subject(s) - renal replacement therapy , medicine , hemofiltration , randomized controlled trial , clinical trial , intensive care medicine , intensive care , acute kidney injury , sample size determination , hemodialysis , surgery , statistics , mathematics
The optimal dose of renal replacement therapy (RRT) in acute renal failure (ARF) is uncertain.